MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines

Diffuse large B-cell lymphoma (DLBCL) is the most frequent type of non-Hodgkin lymphoma. Despite a favorable therapeutic response to first-line chemo-immunotherapy, still 30–40% of patients is refractory, or relapse after this treatment. Thus, alternative strategies must be sought. Previous studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Farina, Floriana Maria, Inguscio, Alessandra, Kunderfranco, Paolo, Cortesi, Alice, Elia, Leonardo, Quintavalle, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520941/
https://www.ncbi.nlm.nih.gov/pubmed/28640256
http://dx.doi.org/10.1038/cddis.2017.291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520941/
https://www.ncbi.nlm.nih.gov/pubmed/28640256
http://dx.doi.org/10.1038/cddis.2017.291

Ejemplares similares